CLINICAL_TRIALS
trial_result
· 2012-03-12
Clinical Trial Update: Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency [Phase 1]
Summary
This clinical trial update reports the completion of a Phase 1 safety study of Syntropin (human growth hormone) for growth hormone deficiency.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Phage Pharmaceuticals, Inc. | Conditions: Growth Hormone Deficiency | Phase 1 | Status: COMPLETED